{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T20:49:04Z","timestamp":1778705344447,"version":"3.51.4"},"reference-count":64,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIAID\/NIH","award":["2R01AI056189"],"award-info":[{"award-number":["2R01AI056189"]}]},{"name":"Institute for OneWorld Health"},{"name":"NIH Office of Research Infrastructure Programs","award":["P40 OD010440"],"award-info":[{"award-number":["P40 OD010440"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Biochemical Parasitology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.molbiopara.2013.12.002","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:02:04Z","timestamp":1389200524000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Nitazoxanide: Nematicidal mode of action and drug combination studies"],"prefix":"10.1016","volume":"193","author":[{"given":"Vishal S.","family":"Somvanshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian L.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffi V.","family":"Aroian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molbiopara.2013.12.002_bib0005","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/01.inf.0000132228.00778.e4","article-title":"Global health impact of soil-transmitted nematodes","volume":"23","author":"Cappello","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0010","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.pt.2003.10.002","article-title":"Soil-transmitted helminth infections: updating the global picture","volume":"19","author":"de Silva","year":"2003","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0015","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(06)68653-4","article-title":"Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm","volume":"367","author":"Bethony","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0020","series-title":"Disease Control Priorities in Developing Countries","first-page":"467","article-title":"Helminth infections: Soil-transmitted helminth infections and schistosomiasis","author":"Hotez","year":"2006"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0025","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00006454-198908000-00009","article-title":"Hookworm disease in children","volume":"8","author":"Hotez","year":"1989","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0030","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1001\/jama.299.16.1937","article-title":"Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis","volume":"299","author":"Keiser","year":"2008","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpara.2009.11.001","article-title":"Unresolved issues in anthelmintic pharmacology for helminthiases of humans","volume":"40","author":"Geary","year":"2010","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1895\/wormbook.1.143.1","article-title":"Anthelmintic drugs","author":"Holden-Dye","year":"2007","journal-title":"WormBook"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0045","doi-asserted-by":"crossref","first-page":"792","DOI":"10.4269\/ajtmh.2011.11-0003","article-title":"Epidemiology of hookworm infection in Kintampo North Municipality, Ghana: patterns of malaria coinfection, anemia, and albendazole treatment failure","volume":"84","author":"Humphries","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0050","doi-asserted-by":"crossref","first-page":"e1417","DOI":"10.1371\/journal.pntd.0001417","article-title":"Low efficacy of single-dose albendazole and mebendazole against hookworm and effect on concomitant helminth infection in Lao PDR","volume":"6","author":"Soukhathammavong","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0055","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1179\/136485909X398320","article-title":"A spot-check of the efficacies of albendazole or levamisole, against soil-transmitted helminthiases in young Ungujan children, reveals low frequencies of cure","volume":"103","author":"Stothard","year":"2009","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0060","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1371\/journal.pntd.0000322","article-title":"Tribendimidine and albendazole for treating soil-transmitted helminths Strongyloides stercoralis and Taenia spp.: open-label randomized trial","volume":"2","author":"Steinmann","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0065","doi-asserted-by":"crossref","first-page":"511","DOI":"10.4269\/ajtmh.1984.33.511","article-title":"Nitazoxanide in the treatment of Taenia saginata and Hymenolepis nana infections","volume":"33","author":"Rossignol","year":"1984","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0070","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0035-9203(98)90804-5","article-title":"A double-\u2018blind\u2019 placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in AIDS patients in Mexico","volume":"92","author":"Rossignol","year":"1998","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0075","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1086\/322038","article-title":"Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or E. dispar: a randomized, double-blind, placebo-controlled study of nitazoxanide","volume":"184","author":"Rossignol","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0080","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/jac\/49.1.103","article-title":"In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis","volume":"49","author":"Adagu","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0085","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1345\/aph.1H340","article-title":"Emerging therapies in the treatment of Clostridium difficile-associated disease","volume":"40","author":"Jodlowski","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0090","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1086\/506351","article-title":"Nitazoxanide for the treatment of Clostridium difficile colitis","volume":"43","author":"Musher","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0095","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11908-008-0016-9","article-title":"Nitazoxanide to treat persistent Clostridium difficile colitis","volume":"10","author":"Bobak","year":"2008","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0100","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1128\/AAC.42.11.2836","article-title":"Nitazoxanide, a potential drug for eradication of Helicobacter pylori with no cross-resistance to metronidazole","volume":"42","author":"Megraud","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0105","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(06)68852-1","article-title":"Effect of nitazoxanide for treatment of severe rotavirus diarrhoea: randomised double-blind placebo-controlled trial","volume":"368","author":"Rossignol","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0110","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1365-2036.2008.03781.x","article-title":"Clinical trial: randomized, double-blind, placebo-controlled study of nitazoxanide monotherapy for the treatment of patients with chronic hepatitis C genotype 4","volume":"28","author":"Rossignol","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0115","first-page":"459","article-title":"Treatment of chronic hepatitis C","volume":"100","author":"Bihl","year":"2009","journal-title":"Minerva Med"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0120","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.antiviral.2007.08.005","article-title":"Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication","volume":"77","author":"Korba","year":"2008","journal-title":"Antiviral Res"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0125","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1517\/14656566.7.7.953","article-title":"Nitazoxanide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infections","volume":"7","author":"Hemphill","year":"2006","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0130","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1365-2036.2006.03033.x","article-title":"Nitazoxanide in the treatment of acquired immune deficiency syndrome-related cryptosporidiosis: results of the United States compassionate use program in 365 patients","volume":"24","author":"Rossignol","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0135","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004932.pub2","article-title":"Prevention and treatment of cryptosporidiosis in immunocompromised patients","volume":"1","author":"Abubakar","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0140","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/INF.0b013e318186257b","article-title":"Nitazoxanide for severe cryptosporidial diarrhea in human immunodeficiency virus infected children","volume":"27","author":"Abraham","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0145","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0011-393X(98)85006-6","article-title":"Nitazoxanide in the treatment of patients with intestinal protozoan and helminthic infections: a report on 546 patients in Egypt","volume":"59","author":"Abaza","year":"1998","journal-title":"Curr Ther Res"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0150","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0304-4017(99)00042-4","article-title":"Frontiers in anthelmintic pharmacology","volume":"84","author":"Geary","year":"1999","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0155","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4269\/ajtmh.2002.66.251","article-title":"Nitazoxanide compared with quinfamide and mebendazole in the treatment of helminthic infections and intestinal protozoa in children","volume":"66","author":"Davila-Gutierrez","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0160","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0035-9203(02)90301-9","article-title":"Comparative clinical studies of nitazoxanide, albendazole and praziquantel in the treatment of ascariasis, trichuriasis and hymenolepiasis in children from Peru","volume":"96","author":"Juan","year":"2002","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0165","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1086\/428839","article-title":"Nitazoxanide: a new thiazolide antiparasitic agent","volume":"40","author":"Fox","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0170","doi-asserted-by":"crossref","first-page":"384","DOI":"10.4269\/ajtmh.2003.68.384","article-title":"Epidemiology and control of intestinal parasites with nitazoxanide in children in Mexico","volume":"68","author":"Diaz","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0175","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0035-9203(97)90531-9","article-title":"Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico","volume":"91","author":"Romero Cabello","year":"1997","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0180","doi-asserted-by":"crossref","first-page":"e1685","DOI":"10.1371\/journal.pntd.0001685","article-title":"Efficacy and safety of nitazoxanide, albendazole, and nitazoxanide-albendazole against Trichuris trichiura infection: a randomized controlled trial","volume":"6","author":"Speich","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0185","doi-asserted-by":"crossref","first-page":"e70702","DOI":"10.1371\/journal.pone.0070702","article-title":"An extensive comparison of the effect of anthelmintic classes on diverse nematodes","volume":"8","author":"Hu","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0190","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1128\/AAC.01159-06","article-title":"Antiparasitic drug nitazoxanide inhibits the pyruvate oxidoreductases of Helicobacter pylori, selected anaerobic bacteria and parasites, and Campylobacter jejuni","volume":"51","author":"Hoffman","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0195","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/jac\/dkm205","article-title":"Characterization of Giardia lamblia WB C6 clones resistant to nitazoxanide and to metronidazole","volume":"60","author":"Muller","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0200","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/jac\/dkn142","article-title":"Identification of differentially expressed genes in a Giardia lamblia WB C6 clone resistant to nitazoxanide and metronidazole","volume":"62","author":"Muller","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0205","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1128\/AAC.01548-06","article-title":"A novel Giardia lamblia nitroreductase, GlNR1, interacts with nitazoxanide and other thiazolides","volume":"51","author":"Muller","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0210","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/jac\/dkr029","article-title":"Nitroreductase (GlNR1) increases susceptibility of Giardia lamblia and Escherichia coli to nitro drugs","volume":"66","author":"Nillius","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0215","doi-asserted-by":"crossref","first-page":"29798","DOI":"10.1074\/jbc.M109.029470","article-title":"Thiazolides, a new class of anti-influenza molecules targeting viral hemagglutinin at the post-translational level","volume":"284","author":"Rossignol","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0220","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000007200","article-title":"Nitazoxanide, a nitrothiazolide antiparasitic drug, is an anti-Helicobacter pylori agent with anti-vacuolating toxin activity","volume":"45","author":"Yamamoto","year":"1999","journal-title":"Chemotherapy"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0225","doi-asserted-by":"crossref","first-page":"e499","DOI":"10.1371\/journal.pntd.0000499","article-title":"The new anthelmintic tribendimidine is an l-type (levamisole and pyrantel) nicotinic acetylcholine receptor agonist","volume":"3","author":"Hu","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0230","first-page":"139","article-title":"Assays for toxicity studies in C. elegans with Bt crystal proteins","volume":"351","author":"Bischof","year":"2006","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0235","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/genetics\/77.1.71","article-title":"The genetics of Caenorhabditis elegans","volume":"77","author":"Brenner","year":"1974","journal-title":"Genetics"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0240","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1093\/emboj\/16.19.5867","article-title":"avr-15 encodes a chloride channel subunit that mediates inhibitory glutamatergic neurotransmission and ivermectin sensitivity in Caenorhabditis elegans","volume":"16","author":"Dent","year":"1997","journal-title":"EMBO J"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0245","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1073\/pnas.0538072100","article-title":"Bacillus thuringiensis crystal proteins that target nematodes","volume":"100","author":"Wei","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0250","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.1073\/pnas.0912327107","article-title":"Discovery of a highly synergistic anthelmintic combination that shows mutual hypersusceptibility","volume":"107","author":"Hu","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0255","series-title":"The nematode Caenorhabditis elegans","first-page":"587","article-title":"Methods","author":"Sulston","year":"1988"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0260","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/genetics\/131.3.609","article-title":"A genetic mapping system in Caenorhabditis elegans based on polymorphic sequence-tagged sites","volume":"131","author":"Williams","year":"1992","journal-title":"Genetics"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0265","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0270","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou\u2013Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0275","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00436-003-0974-7","article-title":"Nematocidal activity of nitazoxanide in laboratory models","volume":"91","author":"Fonseca-Salamanca","year":"2003","journal-title":"Parasitol Res"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0280","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1073\/pnas.97.6.2674","article-title":"The genetics of ivermectin resistance in Caenorhabditis elegans","volume":"97","author":"Dent","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0285","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ijpara.2010.11.009","article-title":"Activity of novel nicotinic anthelmintics in cut preparations of Caenorhabditis elegans","volume":"41","author":"Ruiz-Lancheros","year":"2011","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0290","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nchembio.380","article-title":"A predictive model for drug bioaccumulation and bioactivity in Caenorhabditis elegans","volume":"6","author":"Burns","year":"2010","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0295","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1242\/jeb.200.10.1509","article-title":"Reporter gene constructs suggest the Caenorhabditis elegans avermectin receptor b-subunit is expressed solely in the pharynx","volume":"200","author":"Laughton","year":"1997","journal-title":"J Exp Biol"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0300","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0166-6851(99)00120-6","article-title":"Ligand-gated chloride channel subunits encoded by the Haemonchus contortus and Ascaris suum orthologues of the Caenorhabditis elegans gbr-2 (avr-14) gene","volume":"103","author":"Jagannathan","year":"1999","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0305","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.ijpara.2004.04.010","article-title":"An ivermectin-sensitive glutamate-gated chloride channel subunit from Dirofilaria immitis","volume":"34","author":"Yates","year":"2004","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0310","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.ijpara.2011.04.003","article-title":"Altered avr-14B gene transcription patterns in ivermectin-resistant isolates of the cattle parasites, Cooperia oncophora and Ostertagia ostertagi","volume":"41","author":"El-Abdellati","year":"2011","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0315","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1017\/S0031182005008218","article-title":"Glutamate-gated chloride channels and the mode of action of the avermectin\/milbemycin anthelmintics","volume":"131","author":"Wolstenholme","year":"2005","journal-title":"Parasitology"},{"key":"10.1016\/j.molbiopara.2013.12.002_bib0320","first-page":"98","article-title":"Nitazoxanide: in vitro and in vivo drug effects against Trichuris muris and Ancylostoma ceylanicum, alone or in combination","volume":"2","author":"Tritten","year":"2012","journal-title":"Int J Parasitol: Drugs Drug Resist"}],"container-title":["Molecular and Biochemical Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166685113001667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166685113001667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T23:44:09Z","timestamp":1647906249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166685113001667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0166685113001667"],"URL":"https:\/\/doi.org\/10.1016\/j.molbiopara.2013.12.002","relation":{},"ISSN":["0166-6851"],"issn-type":[{"value":"0166-6851","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitazoxanide: Nematicidal mode of action and drug combination studies","name":"articletitle","label":"Article Title"},{"value":"Molecular and Biochemical Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molbiopara.2013.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}